Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal live influenza vaccine in pediatric atopic dermatitis patients treated with dupilumab
jRCTs031240442Recruiting
- Sponsor
- Chiba University Hospital
- Start
- Nov 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of live attenuated influenza vaccine and dupilumab in influenza, sponsored by Chiba University Hospital. Primary endpoint: Primary immunogenicity endpoint. Started Nov 2024; status: recruiting.
02
Drugs
live attenuated influenza vaccinedupilumab
03
Conditions
influenza
Beyond the preview
Go deeper on jRCTs031240442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240442.